The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

METHAMINODIAZEPOXIDE (LIBRIUM) IN CHRONIC REFRACTORY ANXIETY

Published Online:https://doi.org/10.1176/ajp.117.8.743

Methaminodiazepoxide appears to be quite effective in a wide range of mental disorders where severe anxiety is present. In each instance where there was marked or moderate improvement in the study group, the patient became more sociable, conversant, and noticeably less fearful and preoccupied.

I am grateful to the Roche Laboratories for supplying the drug used in this study. and to the staff of Warren State Hospital for their participation in this effort.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.